Recipient | Donor | |
---|---|---|
Male (%) | 37 (74%) | 36 (72%) |
Female (%) | 13 (26%) | 14 (28%) |
Age (yrs) | 51.3 ± 11.1 (16 - 67) | 53.2 ± 17.2 (19 - 86) |
BMI (kg/m2) | 25.7 ± 4.73 (16.6 - 42.9) | 24.3 ± 3.3 (16.0- 31.0) |
MELD | 21 ± 10.4 (6 - 40) | |
RRT before TPL (%) | 8 (16%) | |
HRS before TPL (%) | 17 (34%) | |
SAPS II | 30 ± 19 (0 - 91) | |
Creatinine (μmol/l) | 121 ± 117 (40 - 814) | |
Hematocrit (%) | 31.4 ± 7.6 (18.8 - 49.6) | |
Platelets (103/μl) | 106 ± 65 (33 - 324) | |
INR | 1.5 ± 0.6 (0.9 - 4.3) | |
Bilirubin (μmol/l) | 148 ± 198 (5 - 875) | |
Etiology of liver disease | ||
HCV (%) | 17 (34%) | |
HBV (%) | 3 (6%) | |
HCC (%) | 10 (20%) | |
Alcoholic liver cirrhosis (%) | 6 (12%) | |
Cholangiocarcinoma (%) | 2 (4%) | |
Others1 (%) | 12 (24%) | |
Cadaveric Donor (%) | 44 (88%) | |
Living Donor (%) | 6 (12%) | |
Extended donor graft criteria (%) | 16 (32%) |